Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP575846.RAaMc80DtKajR6xARuWNI2WLpF3MBS9uc75Oq21elvxtk130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575846.RAaMc80DtKajR6xARuWNI2WLpF3MBS9uc75Oq21elvxtk130_provenance.
• NP521428.RAhinbR8SIggaGPrTxvPcWvfRKah5eV48QCWEPfT_1UtU130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521428.RAhinbR8SIggaGPrTxvPcWvfRKah5eV48QCWEPfT_1UtU130_provenance.
• NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607710.RAkYOGCGEl5WbFUgbHHfUeckQGC1DYRlydqjrkjc_hHsg130_provenance.
• NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520371.RAXhAsfecGfjF4si2EQESWRH4hjrWj3Hik3RgZAllovyA130_provenance.
• NP734206.RA9KSDrmq46_5884Gz--KVOOLqXE1OlNGbwIf2McmMlPY130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734206.RA9KSDrmq46_5884Gz--KVOOLqXE1OlNGbwIf2McmMlPY130_provenance.
• NP621372.RAWKo7kExq19RMeIO8ocNsKQLUrps1orBu9CNiTiQCyFg130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621372.RAWKo7kExq19RMeIO8ocNsKQLUrps1orBu9CNiTiQCyFg130_provenance.
• NP621450.RAfxw6B9Y5sH8UDn3pUETJqekWe0KR9F9z7DTfhj6hq0k130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621450.RAfxw6B9Y5sH8UDn3pUETJqekWe0KR9F9z7DTfhj6hq0k130_provenance.
• NP1089485.RAcbCuftzIltJjbBvJ7Zg-I0W_PZ-nyI_qpfxKi-39S3w130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089485.RAcbCuftzIltJjbBvJ7Zg-I0W_PZ-nyI_qpfxKi-39S3w130_provenance.
• NP622724.RABvJeLDzdSwPIx55-Q7IBmDlUCsgBI9oHvCJW4CFdAXU130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622724.RABvJeLDzdSwPIx55-Q7IBmDlUCsgBI9oHvCJW4CFdAXU130_provenance.
• NP624040.RAi-6MhxH8nT0bCAvb2r3o82fdzgDpNmK0Eij8nv8nL_k130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624040.RAi-6MhxH8nT0bCAvb2r3o82fdzgDpNmK0Eij8nv8nL_k130_provenance.
• NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625180.RAp7fu3ex6jDrVN9kCc9GErJbDi_lOr7uOfThfAedrZz8130_provenance.
• NP1089492.RAqqfv8fBLkoem8g4kgA1hdAiL-d4kHPgfoovW1e8dTh4130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089492.RAqqfv8fBLkoem8g4kgA1hdAiL-d4kHPgfoovW1e8dTh4130_provenance.
• NP622772.RAFOITZOWpzQ7_FK0z_ze4uE_O4-yGJSzSUqATNQgYp6o130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622772.RAFOITZOWpzQ7_FK0z_ze4uE_O4-yGJSzSUqATNQgYp6o130_provenance.
• NP624088.RALizoUD5ncW8VMQGyA_ZWUjAnLjuE-cxoRjuNhHiTVIc130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624088.RALizoUD5ncW8VMQGyA_ZWUjAnLjuE-cxoRjuNhHiTVIc130_provenance.
• NP625228.RA6hx0SZkm5Ih17KUyOMwmibHbRcCgZTrV9bliMckCvEc130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625228.RA6hx0SZkm5Ih17KUyOMwmibHbRcCgZTrV9bliMckCvEc130_provenance.
• NP1089493.RAF5MNgkLxJJcxkZ_8B03TN70AaVcMNwXN38JaTxH3cAw130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089493.RAF5MNgkLxJJcxkZ_8B03TN70AaVcMNwXN38JaTxH3cAw130_provenance.
• NP1089484.RA3cqS1l3qV687N1jDfFNGponnMc20sZp6NWC8LCGlvkM130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089484.RA3cqS1l3qV687N1jDfFNGponnMc20sZp6NWC8LCGlvkM130_provenance.
• NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089487.RA1SfKP8oOwg2Oar1-vPMVSNV137nAnghFsU2QSRigmvU130_provenance.
• NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089488.RA9h_YqBSl3eamMq_UWhOi2VxhgXBMWh1kQU6idVfCT1o130_provenance.
• NP1089489.RA2VKCHiYr3ujTuo8VRjdr05HgXzTS61hVm3eB4uM_PQg130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089489.RA2VKCHiYr3ujTuo8VRjdr05HgXzTS61hVm3eB4uM_PQg130_provenance.
• NP1089490.RA6EkGBqPUGZstOy60jf1ZuLdfihixkPM4s0ebTchDxvc130_assertion description "[Dysregulated epidermal growth factor receptor (EGFR)-phosphoinositide-3-kinase (PI3K)-AKT signaling is considered pivotal for oral cancer, and the pathway is a potential candidate for therapeutic targeting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1089490.RA6EkGBqPUGZstOy60jf1ZuLdfihixkPM4s0ebTchDxvc130_provenance.